Checkmate Pharmaceuticals

Checkmate Pharma is a clinical-stage biopharmaceutical company developing a new approach for cancer immunotherapy. The clinical programs are focused on enabling more people with cancer to benefit from the promise of novel immunotherapies. They leveraging their expertise in the field of CpG oligonucleotides to discover and develop immunotherapies designed to increase the efficacy of existing immunotherapies and to provide new treatment options for patients and their healthcare providers.

Checkmate Pharmaceutical was founded in 2015 and is headquartered in Cambridge, Massachusetts.

Checkmate Pharmaceuticals headquartered in United States, North America, operates in the Biotechnology, Pharmaceutical, Medical Device, Therapeutics sector. The company focuses on Biotechnology and has secured $13.6B in funding across 80 round(s). With a team of 11-50 employees, Checkmate Pharmaceuticals is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Checkmate Pharmaceuticals, raised $20.0M. Discover more about their projects, partnerships, and impact on our platform.